Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T73331 |
GSK3-IN-3
|
Mitophagy; GSK-3 | Autophagy; PI3K/Akt/mTOR signaling; Stem Cells |
GSK3-IN-3 是一种线粒体自噬 (mitophagy) 诱导剂和GSK-3 抑制剂(IC50 : 3.01 μM),可诱导帕金依赖性线粒体自噬。 GSK3-IN-3 具有非 ATP 和非底物竞争性,对 6-OHDA 有神经保护作用。 | |||
T9987 |
GSK3-IN-1
|
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
GSK3-IN-1是一种 GSK3B-糖原合酶激酶3β抑制剂。 | |||
T35555 |
GSK-3/CDK5/CDK2-IN-1
GSK-3/CDK5/CDK2-IN-1 |
||
GSK-3/CDK5/CDK2-IN-1 is an imidazole derivative compound that inhibits cdk5, cdk2, and GSK-3.it has demonstrated applications in cancer research and the study of neurodegenerative diseases [1]. | |||
T64366 |
GSK3-IN-4
|
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
GSK3-IN-4是一种 GSK-3抑制剂,对 GSK-3α和 GSK-3β的IC50值为 0.101-1 μM。 | |||
T2608 |
CHIR-98014
CHIR 98014,CT98014,CHIR98014 |
FGFR; GSK-3; Src; S6 Kinase | Angiogenesis; MAPK; PI3K/Akt/mTOR signaling; Stem Cells; Tyrosine Kinase/Adaptors |
CHIR-98014 (CT98014) 是有效的,细胞通透的GSK-3抑制剂,可抑制 GSK-3α (IC50:0.65 nM) 和 GSK-3β (IC50:0.58 nM) 的活性,对 cdc2 和 erk2 的作用较弱。 | |||
T16670 |
PS210
|
PDK | PI3K/Akt/mTOR signaling |
PS210 是针对 PDK1的 PIF 结合口袋的、选择性的、有效的 PDK1激活剂,对其他蛋白激酶无活性。在细胞中,它的前药 PS423 可作为 PDK1的底物选择性抑制剂,抑制 S6K 的磷酸化和活化。 | |||
T30807 |
CG0009
CG-0009,CG 0009 |
||
CG0009 is a potent and highly selective glycogen synthase kinase 3 (GSK3) inhibitor that inhibitions proliferation, induces apoptosis, and activates the p53-Bax pathway in breast cancer cells through cyclin D1 depletion. CG0009 inhibit breast cancer cell | |||
T74033 |
6-Me-ATP
|
||
6-Me-ATP(N6-Methyl-ATP)为ATP的N6修饰衍生物。该化合物与GSK3β结合亲和力显著,能有效作为GSK3β催化底物肽磷酸化的磷酸基团供体。 | |||
T35541 |
Lipoxygenin
|
||
Lipoxygenin is an inhibitor of 5-lipoxygenase (5-LO) with an IC50value of 5 μM for inhibition of 5-LO product synthesis in isolated human granulocytes stimulated with the cation ionophore A23187 .1It inhibits hedgehog-dependent signaling in Shh-LIGHT2 cells and TGF-β-, activin A-, bone morphogenic protein (BMP)-, or Wnt-dependent signaling in HEK293T cells (IC50s = 9.3, 3.2, 8.2, 9.6, and 3.7 μM, respectively, in luciferase reporter assays). Lipoxygenin (5 and 10 μM) increases levels of troponin... |